A new biomarker for subthalamic deep brain stimulation for patients with advanced Parkinson's disease—a pilot study. (19th October 2015)

• Record Type: Journal Article
• Authors: Gmel, Gerrit E; Hamilton, Tara J; Obradovic, Milan; Gorman, Robert B; Single, Peter S; Chenery, Helen J; Coyne, Terry; Silburn, Peter A; Parker, John L
• Is Part Of: Journal of neural engineering. Volume 12:Number 6(2015:Dec.)
• Publication Date: 2015-10-19
• Subjects: neuromodulation -- Parkinson's disease -- deep brain stimulation -- evoked compound action potentials -- evoked potentials; Neurosciences -- Periodicals; Biomedical engineering -- Periodicals; 612.8
• DOI: 10.1088/1741-2560/12/6/066013
• Languages: English
• ISSNs: 1741-2560

Abstract

Abstract: Objective. Deep brain stimulation (DBS) has become the standard treatment for advanced stages of Parkinson's disease (PD) and other motor disorders. Although the surgical procedure has improved in accuracy over the years thanks to imaging and microelectrode recordings, the underlying principles that render DBS effective are still debated today. The aim of this paper is to present initial findings around a new biomarker that is capable of assessing the efficacy of DBS treatment for PD which could be used both as a research tool, as well as in the context of a closed-loop stimulator. Approach. We have used a novel multi-channel stimulator and recording device capable of measuring the response of nervous tissue to stimulation very close to the stimulus site with minimal latency, rejecting most of the stimulus artefact usually found with commercial devices. We have recorded and analyzed the responses obtained intraoperatively in two patients undergoing DBS surgery in the subthalamic nucleus (STN) for advanced PD. Main results. We have identified a biomarker in the responses of the STN to DBS. The responses can be analyzed in two parts, an initial evoked compound action potential arising directly after the stimulus onset, and late responses (LRs), taking the form of positive peaks, that follow the initial response. We have observed a morphological change in the LRs coinciding with a decrease in the rigidity of the patients. Significance. These initial results could lead to a better characterization of the DBS therapy, and the design of adaptive DBS algorithms that could significantly improve existing therapies and help us gain insights into the functioning of the basal ganglia and DBS.